Literature DB >> 14751871

Radical surgery for mesothelioma.

Tom Treasure, David Waller, Simon Swift, Julian Peto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14751871      PMCID： PMC324440          DOI： 10.1136/bmj.328.7434.237

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

Review 1.  Statement on malignant mesothelioma in the United Kingdom.

Authors: 
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

2.  Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems.

Authors:  J G Edwards; K R Abrams; J N Leverment; T J Spyt; D A Waller; K J O'Byrne
Journal:  Thorax       Date:  2000-09       Impact factor: 9.139

3.  Annual deaths from mesothelioma in Britain to reach 2000 by 2010.

Authors:  Caroline White
Journal:  BMJ       Date:  2003-06-28

Review 4.  Contemporary management of malignant pleural mesothelioma.

Authors:  E G Butchart
Journal:  Oncologist       Date:  1999

5.  Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients.

Authors:  E G Butchart; T Ashcroft; W C Barnsley; M P Holden
Journal:  Thorax       Date:  1976-02       Impact factor: 9.139

6.  Analysis of current trends in United States mesothelioma incidence.

Authors:  B Price
Journal:  Am J Epidemiol       Date:  1997-02-01       Impact factor: 4.897

Review 7.  Multicenter randomized controlled trial of the management of unresectable malignant mesothelioma proposed by the British Thoracic Society and the British Medical Research Council.

Authors:  David J Girling; Martin F Muers; Wendi Qian; Dawn Lobban
Journal:  Semin Oncol       Date:  2002-02       Impact factor: 4.929

8.  Radical surgery for mesothelioma: how can we obtain evidence?

Authors:  Tom Treasure; Simon Swift; Carol Tan
Journal:  World J Surg       Date:  2003-06-06       Impact factor: 3.352

9.  Continuing increase in mesothelioma mortality in Britain.

Authors:  J Peto; J T Hodgson; F E Matthews; J R Jones
Journal:  Lancet       Date:  1995-03-04       Impact factor: 79.321

10.  The European mesothelioma epidemic.

Authors:  J Peto; A Decarli; C La Vecchia; F Levi; E Negri
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640
  10 in total
  5 in total

1.  Current therapies for malignant pleural mesothelioma.

Authors:  Takashi Nakano
Journal:  Environ Health Prev Med       Date:  2008-02-28       Impact factor: 3.674

2.  Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study.

Authors:  Tom Treasure; Loic Lang-Lazdunski; David Waller; Judith M Bliss; Carol Tan; James Entwisle; Michael Snee; Mary O'Brien; Gill Thomas; Suresh Senan; Ken O'Byrne; Lucy S Kilburn; James Spicer; David Landau; John Edwards; Gill Coombes; Liz Darlison; Julian Peto
Journal:  Lancet Oncol       Date:  2011-06-30       Impact factor: 41.316

3.  Investigational approaches for mesothelioma.

Authors:  Veerle F Surmont; Eric R E van Thiel; Karim Vermaelen; Jan P van Meerbeeck
Journal:  Front Oncol       Date:  2011-08-22       Impact factor: 6.244

4.  Mesothelioma with non-pleural malignancy: a red herring or just an uncommon pairing?

Authors:  Andrew J Drain; Kourosh Saeb-Parsy; Amit K Shah; D Rassl; Andrew J Ritchie
Journal:  J Cardiothorac Surg       Date:  2006-11-01       Impact factor: 1.637

5.  Surgery in the treatment of malignant pleural mesothelioma: recruitment into trials should be the default position.

Authors:  Avijit Datta; Rhiannon Smith; Francesca Fiorentino; Tom Treasure
Journal:  Thorax       Date:  2013-06-12       Impact factor: 9.139
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.